Brian Overstreet

Brian is an entrepreneur focused on data-intensive enterprise solutions. He is currently a co-founder and the president of AdverseEvents, which provides accurate and unbiased adverse event data for FDA approved drugs with the goal to reduce side effects and associated costs in the healthcare system. Prior to founding AdverseEvents, Brian was a co-founder of Sagient Research Systems. He served as the company's president and CEO from 1999 to 2009 and as the Chairman of the Board from 2010 until the company's acquisition in May 2012 by Informa plc. Sagient is a publisher of specialized research and data. They develop, produce, and sell proprietary research products to global enterprises, including pharmaceutical companies, investment banks, mutual and hedge funds, academic institutions, and government agencies. Along with his wife, Dr. Kerith Overstreet, Brian also owns and manages Bruliam Wines a boutique producer of pinot noir and zinfandel located in California’s Russian River Valley. Founded in 2008 with a mandate to give all profits to charity, Bruliam has garnered numerous 90+ point scores while supporting over 40 local and national charitable organizations. Brian earned a B.A. in Political Science from the University of California at Berkeley.